|
Real-time Estimate
Cboe BZX
19:45:22 13/01/2026 GMT
|
5-day change
|
1st Jan Change
|
|
179.20 USD
|
-3.46%
|
 |
-1.75%
|
+1.94%
|
|
01-12 |
Disc Medicine Inc Appoints Lisa Amaya Price as Chief Human Resources Officer
|
CI
| |
12-01 |
Tyra Biosciences, Inc. Appoints Heather Faulds as Chief Regulatory Officer, Effective December 8, 2025
|
CI
| |
11-14 |
Exelixis Insider Sold Shares Worth $4,355,000, According to a Recent SEC Filing
|
MT
| |
21/10/25 |
Climb Bio, Inc. Announces Executive Appointments
|
CI
| |
22/09/25 |
Mallinckrodt plc Announces Executive Changes
|
CI
| |
26/08/25 |
Innovent Biologics, Inc. Appoints Stephen A. Sherwin as an Independent Non-Executive Director and A Member of the Strategy Committee of the Board, Effective August 26, 2025
|
CI
| |
16/07/25 |
Biogen Insider Sold Shares Worth $300,105, According to a Recent SEC Filing
|
MT
| |
16/07/25 |
Satellos Bioscience Inc. Appoints Wildon Farwell as Chief Medical Officer
|
CI
| |
24/06/25 |
Indivior PLC Appoints Tony Kingsley as Independent Non-Executive Director, Effective July 1, 2025
|
CI
| |
12/06/25 |
Ionis Pharmaceuticals, Inc. Announces Executive Changes
|
CI
| |
09/06/25 |
FibroGen, Inc. Announces the Appointment of Michael Kauffman to Its Board of Directors, Effective June 4, 2025
|
CI
| |
03/06/25 |
Entrada Therapeutics, Inc. Appoints Maha Radhakrishnan, M.D., to Its Board of Directors
|
CI
| |
19/05/25 |
Exelixis Insider Sold Shares Worth $1,619,130, According to a Recent SEC Filing
|
MT
| |
03/03/25 |
Ovid Therapeutics Inc. Appoints Stelios Papadopoulos to Its Board of Directors and Member of Audit and Compensation Committees
|
CI
| |
27/02/25 |
Indivior Parts Ways With CEO as Leadership Shakeup Continues
|
DJ
| |
28/01/25 |
EXECUTIVE CHANGES: Smithson changes chairs; British Land taps new COO
|
AN
| |
27/01/25 |
Shield Therapeutics plc Appoints Anders Lundstrom as CEO, Effective 1 February 2025
|
CI
| |
15/01/25 |
Biogen Inc. Announces Executive Changes Effective March 1, 2025
|
CI
| |
10/01/25 |
Biogen Inc. Announces Appointment of Adam Feire as Head of Business Development and External Innovation
|
CI
| |
29/10/24 |
Biogen Inc. Appoints Daniel Quirk as Chief Medical Officer and Head of Medical Affairs
|
CI
| |
28/10/24 |
Biogen Finance Chief Michael McDonnell to Retire; Successor Named
|
MT
| |
28/10/24 |
Biogen Inc. Announces Chief Financial Officer Changes
|
CI
| |
28/10/24 |
Biogen Inc. Announces Executive Changes
|
CI
| |
24/10/24 |
Incannex Healthcare Inc. Announces Appointment of Dr. Lou Barbato as Chief Medical Officer
|
CI
| |
02/10/24 |
Oculis Holding AG Announces Appointment of Daniel S. Char as Chief Legal Officer
|
CI
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
